|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
37,070,000 |
Market
Cap: |
2.35(B) |
Last
Volume: |
12,537,091 |
Avg
Vol: |
5,789,016 |
52
Week Range: |
$63.44 - $63.44 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Baker/tisch Investments, Lp |
Director |
|
2017-05-31 |
4 |
OE |
$18.13 |
$897,435 |
I/I |
49,500 |
328,877 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2017-05-23 |
4 |
AS |
$29.40 |
$146,981 |
D/D |
(5,000) |
331,103 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2017-05-23 |
4 |
OE |
$23.31 |
$116,550 |
D/D |
5,000 |
336,103 |
|
- |
|
Cohen Fred E |
Director |
|
2017-05-19 |
4 |
S |
$29.54 |
$243,745 |
D/D |
(8,250) |
65,895 |
|
- |
|
Cohen Fred E |
Director |
|
2017-05-19 |
4 |
OE |
$14.37 |
$118,553 |
D/D |
8,250 |
74,145 |
|
- |
|
Cohen Fred E |
Director |
|
2017-05-18 |
4 |
S |
$29.88 |
$493,040 |
D/D |
(16,500) |
65,895 |
|
- |
|
Cohen Fred E |
Director |
|
2017-05-18 |
4 |
OE |
$17.59 |
$297,743 |
D/D |
16,500 |
82,395 |
|
- |
|
Cohen Fred E |
Director |
|
2017-05-16 |
4 |
S |
$30.68 |
$253,102 |
D/D |
(8,250) |
65,895 |
|
- |
|
Cohen Fred E |
Director |
|
2017-05-16 |
4 |
OE |
$18.13 |
$149,573 |
D/D |
8,250 |
74,145 |
|
- |
|
Radford Jason W. |
Chief Legal Officer |
|
2017-05-15 |
4 |
D |
$30.81 |
$38,605 |
D/D |
(1,253) |
24,902 |
|
- |
|
Popovits Kimberly J |
President and CEO |
|
2017-05-03 |
4 |
AS |
$31.61 |
$158,849 |
D/D |
(5,000) |
78,236 |
|
- |
|
Popovits Kimberly J |
President and CEO |
|
2017-05-03 |
4 |
OE |
$17.33 |
$86,650 |
D/D |
5,000 |
83,236 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2017-04-24 |
4 |
AS |
$31.46 |
$157,323 |
D/D |
(5,000) |
331,103 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2017-04-24 |
4 |
OE |
$23.31 |
$116,550 |
D/D |
5,000 |
336,103 |
|
- |
|
Popovits Kimberly J |
President and CEO |
|
2017-04-03 |
4 |
AS |
$31.30 |
$156,507 |
D/D |
(5,000) |
78,236 |
|
- |
|
Popovits Kimberly J |
President and CEO |
|
2017-04-03 |
4 |
OE |
$17.33 |
$103,992 |
D/D |
5,000 |
83,236 |
|
- |
|
Graham Ginger L |
Director |
|
2017-04-01 |
4 |
A |
$31.49 |
$9,982 |
I/I |
317 |
8,829 |
|
- |
|
Baker/tisch Investments, Lp |
Director |
|
2017-04-01 |
4 |
A |
$31.49 |
$119,788 |
I/I |
3,804 |
320,627 |
|
- |
|
Cohen Fred E |
Director |
|
2017-04-01 |
4 |
A |
$31.49 |
$9,982 |
D/D |
317 |
65,895 |
|
- |
|
Fuchs Henry J |
Director |
|
2017-04-01 |
4 |
A |
$31.49 |
$9,982 |
D/D |
317 |
4,608 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2017-03-23 |
4 |
AS |
$31.26 |
$156,295 |
D/D |
(5,000) |
331,103 |
|
- |
|
Shak Steven |
Chief Scientific Officer |
|
2017-03-23 |
4 |
OE |
$23.31 |
$116,550 |
D/D |
5,000 |
336,103 |
|
- |
|
Popovits Kimberly J |
President and CEO |
|
2017-03-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
488 |
199,487 |
|
- |
|
Popovits Kimberly J |
President and CEO |
|
2017-03-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
876 |
199,975 |
|
- |
|
Leber Laura |
Chief Communication Officer |
|
2017-03-20 |
4 |
AS |
$31.88 |
$97,941 |
D/D |
(3,072) |
14,627 |
|
- |
|
1769 Records found
|
|
Page 18 of 71 |
|
|